Lodi R, Taylor D J, Schapira A H
Dipartimento di Medicina Clinica e Biotecnologia Applicata, Università di Bologna, Italy.
Biol Signals Recept. 2001 May-Aug;10(3-4):263-70. doi: 10.1159/000046891.
Friedreich ataxia (FRDA) is an autosomal recessive degenerative disorder caused in the vast majority of cases by a GAA triplet expansion in the FRDA gene on chromosome 9q13. The FRDA gene product, frataxin, is a widely expressed mitochondrial protein which is severely reduced in FRDA patients. Loss of the homologue of frataxin in yeast is associated with mitochondrial iron overload, increased sensitivity to oxidative stress and profound deficit of oxidative phosphorylation. The demonstration that the human pathology of FRDA is also characterised by mitochondrial iron accumulation, deficit of respiratory chain complex activities and in vivo deficit of tissue energy metabolism establishes FRDA as a 'new' nuclear encoded mitochondrial disease.
弗里德赖希共济失调(FRDA)是一种常染色体隐性退行性疾病,绝大多数病例是由9号染色体q13上FRDA基因中的GAA三联体扩增引起的。FRDA基因产物——酵母辅酶Q蛋白,是一种广泛表达的线粒体蛋白,在FRDA患者中含量严重降低。酵母中酵母辅酶Q蛋白同源物的缺失与线粒体铁过载、对氧化应激敏感性增加以及氧化磷酸化严重缺陷有关。FRDA的人类病理学特征同样为线粒体铁蓄积、呼吸链复合物活性缺陷以及体内组织能量代谢缺陷,这表明FRDA是一种“新型”的核编码线粒体疾病。